Cerevance to Participate in the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit GlobeNewswire November 17, 2025 BOSTON, Nov. 17, 2025 (GLOBE NEWSWIRE) — Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today announced participation in a panel discussion at the TD Cowen […]

SAN FRANCISCO, CA / ACCESS Newswire / November 17, 2025 / National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Baxter International, Inc. ("Baxter") (NYSE:BAX) who purchased or otherwise acquired Baxter common stock between February 23, 2022 and July 30, 2025, inclusive (the "Class Period") to contact us immediately regarding the

Koppers Holdings Inc. (NYSE: KOP), an integrated global provider of treated wood products, wood treatment chemicals and carbon compounds, today announced that the company will host meetings with the investment community as part of its participation in the Southwest IDEAS Investor Conference, which will be held in Dallas, on November 20, 2025. https://mma.prnewswire.com/media/432033/Koppers_Holdings_Inc_Logo.jpg Koppers management

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Six Flags Entertainment Corporation f/k/a CopperSteel HoldCo, Inc. (NYSE: FUN) common stock pursuant or traceable to the company's registration statement and prospectus issued in connection with the July 1, 2024 merger of legacy Six Flags Entertainment Corporation (“Legacy Six Flags”) with Cedar Fair,

NEW YORK, NY / ACCESS Newswire / November 17, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=177682&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

(NASDAQ:CMND),(Frankfurt:CWY0),(TSX-V:NTLX),(NASDAQ:SPRC), Vancouver, Canada, Nov. 17, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the filing of an Israeli patent application for its innovative combination therapy of 5-methoxy-2-aminoindane

Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression GlobeNewswire November 17, 2025 Vancouver, Canada, Nov. 17, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today

PARIS, Nov. 17, 2025 (GLOBE NEWSWIRE) — Gonixo today introduced its new AI-driven compliance engine, designed to automate user verification while improving operational efficiency and risk management. The system integrates facial recognition, OCR document scanning, and automated data validation within a secure environment. It allows gonixo to onboard clients faster, detect inconsistencies instantly, and ensure

Gonixo Launches AI-Powered KYC and Compliance Engine for Enterprise Clients GlobeNewswire November 17, 2025 PARIS, Nov. 17, 2025 (GLOBE NEWSWIRE) — Gonixo today introduced its new AI-driven compliance engine, designed to automate user verification while improving operational efficiency and risk management. The system integrates facial recognition, OCR document scanning, and automated data validation within a

As gold surges past $4,300 per ounce and silver breaks through $54, a quiet trend is reshaping precious metals exploration: junior mining companies are breathing new life into projects abandoned by industry giants during commodity downturns. The strategy is simple but powerful. Major mining companies spend millions exploring properties, drill dozens of holes, and compile